Erythropoietin recalls
The FDA has published 2 recalls involving Erythropoietin since 2017. The latest was reported on 27 Sep 2017. Most were for particulate matter. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2017
Last 12 months0reported
Class I00% of total
Ongoing0latest 27 Sep 2017
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why erythropoietin is recalled
Companies
By year
All erythropoietin recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Procrit (epoetin alfa)/mL recalled by AmgenProcrit | Amgen | Particulate Matter | Nationwide |
| Drug | CLASS II | Procrit Epoetin Alfa/mL single use vial For Intravenouse recalledProcrit | Amgen | Particulate Matter | PR |
Should you stop taking Erythropoietin?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.